Page last updated: 2024-10-31

modafinil and Non-alcoholic Fatty Liver Disease

modafinil has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Choi, S1
Kim, JA1
Li, H1
Jo, SE1
Lee, H1
Kim, TH1
Kim, M1
Kim, SJ1
Suh, SH1

Other Studies

1 other study available for modafinil and Non-alcoholic Fatty Liver Disease

ArticleYear
Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 144

    Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Collagen; Diet, High-Fat; Fatty

2021